Somaxon Pharmaceuticals (SOMX) Misses Q1 Views
Tweet
Share
E-mailGet Alerts SOMX Hot Sheet
Price: $3.00 --0%
Financial Fact:
Selling, general and administrative: 4.38M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Selling, general and administrative: 4.38M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Somaxon Pharmaceuticals (Nasdaq: SOMX) reported Q1 loss of ($0.38), $0.03 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $2.2 million versus the consensus estimate of $2.22 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- ATRenew Inc (RERE) Tops Q2 EPS by 8c ; Offers Guidance
- Ross Stores (ROST) Tops Q2 EPS by 72c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
